MINNETONKA, Minn., Sept. 26, 2013 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that Accelovance, an award-winning, full-service clinical research organization (CRO) focused in early phase Oncology, Vaccines and General Medicine development, has joined the iMedNet™ Partner Program. Designation as an iMedNet Partner will facilitate Accelovance's ability to offer iMedNet EDC to clients as an advanced solution for the data management needs associated with clinical trial programs while providing significant cost savings compared with similar platforms.
"MedNet is extremely pleased to partner with Accelovance, a recognized industry leader," remarked John M. (Rob) Robertson, President and CEO of MedNet Solutions. "Given their well-documented track record of continuously reducing study costs and timelines, their selection of iMedNet EDC to further improve study efficiency is a major testament to the tremendous benefits that iMedNet can deliver. We look forward to working side-by-side with this growing organization and meeting their eClinical needs for many years to come."
"The adoption of the iMedNet technology further expands the breadth of available solutions within our data management offering. We believe this is an attractive option for Sponsors having an early phase concentration and a desire to utilize a state of the art eClinical solution to enhance study efficiencies while maintaining budget discipline," noted Steve Trevisan, President and CEO of Accelovance.
Accelovance's focus on providing the best fit solutions and operational expertise has been a key driver in the growth trajectory of the company. With their acquisition of Radiant Research to bolster their General Medicine experience, continued leadership position in the conduct of Vaccine trials, and key additions to their scientific and operational Oncology staff, they continue on a path of significant expansion.
Please contact MedNet Solutions for more information on iMedNet EDC or the iMedNet Partner Program, and Accelovance for additional details on their comprehensive lineup of clinical research services.
Stay in touch with MedNet:
About MedNet Solutions
MedNet Solutions is a leading healthcare technology company specializing in electronic data capture (EDC) and clinical trial management systems (CTMS) designed for the global life sciences market. MedNet delivers proven, flexible and easy-to-use web-based eClinical solutions that effectively support clinical studies, registries and investigator initiated trials of all types and sizes. Since 2001, MedNet has successfully supported pharmaceutical, medical device, biotechnology and contract research organizations (CROs) on clinical research conducted around the world. These companies trust MedNet to consistently deliver the technology innovation, experience and reliability they need for success. For more information, please visit www.mednetstudy.com.
Headquartered in Rockville, Maryland, Accelovance is a privately held company that has developed a unique operational approach for delivering quality, on time, and cost effective clinical studies. The company was recognized as "Best CRO" with consecutive Industry Excellence awards in 2009, 2010 and 2011. Accelovance tailors its full offering of CRO services to present a clinical solution that meets a sponsor's needs. Accelovance has a 100% owned subsidiary providing CRO services in China. These capabilities can assist clients with global development programs or product registration in China, the fastest growing pharmaceutical market in the world. For more information, visit the company's website at www.accelovance.com or follow them on Twitter at www.twitter.com/Accelovance.
Dirk H. Nelson
Director of Marketing
110 Cheshire Lane, Suite 300
Minnetonka, MN 55305
Vice President, Sales & Marketing
2275 Research Blvd, Suite 700
Rockville, MD 20850
|SOURCE MedNet Solutions|
Copyright©2012 PR Newswire.
All rights reserved